Metastatic Sites As Predictors of Outcome in Renal Cell Carcinoma (Rcc) Patients (Pts) Treated with First-Line Sunitinib (Su) or Sorafenib (So)
Keyword(s):
2015 ◽
Vol 7
(2)
◽
pp. 59-68
◽
Keyword(s):
2009 ◽
Vol 7
(2)
◽
pp. 436
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 12
(12)
◽
pp. 1143-1150
◽